Elias Papatheodorou
Elias Papatheodorou

Board of Directors

Elias Papatheodorou brings with him more tan 25 years of experience.

 

He is currently the CEO of clinical stage fibrosis company Genkyotex $GKTX.PA, acquired by Calliditas $CALT. Prior to Genkyotex, he was the CBO of Covagen, acquired by Janssen, the SVP of Medigene MDG1 and the CEO of Novosom AG, assets acquired by Marina Biotech. Mr. Papatheodorou started his career from Philip Morris International and The Coca Cola company.

 

He has studied in the US at Ithaca College and Cornell University.